Please login to the form below
European biotech
This page shows the latest European biotech news and features for those working in and with pharma, biotech and healthcare.
Mega-mergers dominate as buoyant markets lift biopharma
The biotech has also managed to increase its share price since its launch, a feat not frequently achieved in the sector. ... a new surge in confidence in European biotech.
Latest news
-
Novartis and J&J back latest €400m Medicxi biopharma fund
stage European biotechs, which have tended not have access to as much financial support as their counterparts in the US. ... to Medicxi, with European companies growing in stature and offering improved returns on investment for backers.
-
Illumina sets up first ex-US accelerator site in Cambridge
Boost for UK's golden triangle biotech region. Illumina has set up its first hub for genomics start-up funding outside the US, and has chosen Cambridge in the UK for
-
Gilead strikes $5.1bn deal to bolster ties with Galapagos
to take its stake in the Belgian biotech to 22%, as well as $1.1bn in opt-in payments for two late-stage drug candidates. ... on R&D, said the biotech’s CEO Onno van de Stolpe in a Bloomberg interview.
-
BioNTech raises €290m for mRNA cancer vaccine platform
a European biotech company. ... BioNTech was the first biotech to bring an mRNA-based individualised cancer vaccine targeting neoantigens into clinical trials.
-
Citryll snares €15m backing for its autoimmune disease NETs
New approach to tackling diseases such as lupus, RA. Dutch biotech Citryll has raised 15m ($17m) in first-round financing to help advance its new therapeutic approach to autoimmune diseases.
More from news
Approximately 21 fully matching, plus 34 partially matching documents found.
Latest Intelligence
-
Building Europe’s next breakthrough biotechs
Cambridge's new Biomedical Campus is home to specialist NHS trusts, AstraZeneca's new HQ and biotech firms. ... How can the UK life science ecosystem produce even more biotech start-ups, and propel them to long-term success?
-
25 Women Leaders in UK Healthcare
It’s long been recognised that one of the biggest factors holding back UK and European biotech success has been a paucity of leaders, and that’s why efforts are being ... As well as overseeing the European communications group for Syneos Health, she
-
European venture funding for the life science sector
Capital markets infrastructure is a barrier. European biotech companies continue to find it hard to raise public money in Europe. ... Pockets of success on Euronext mask the fact that leading European venture groups primarily look to the Nasdaq, at least
-
European sites
very large European life science industry offers a fertile ground for investments, collaboration and acquisitions. ... Key findings. In total there are roughly 11, 000 life science companies (biotech, pharma, medtech) across 14 European countries and in
-
Pharma deals in March 2015
One of Bavarian Nordic's sites is in Martinsried, the biotech cluster near Munich. ... The Morphosys story highlights the uncertainty of funding for European biotech companies.
More from intelligence
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest appointments
-
Paris biocluster appoints Stéphane Roques as new chief
Former general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment
-
Apeiron bolsters management board
With more than 25 years’ experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently ... He said: “Apeiron is
-
Novimmune expands senior management team
He is currently a board member of German biotech Epiontis, and has previously served as chief financial officer of PregLem and chairman of Aimago. ... Prior to this, Dr Zimmerman was a European biotech analyst at UBS Investment Bank.
-
MRC Technology appoints director of technology transfer
Farquharson is additionally appointed to the EU Commission's Expert Group, advising on the European Biotech Directive's impact on patent law and R&D activities.
-
Creabilis names Catherine Moukheibir as chairman of the board
After an initial career in strategy consulting and investment banking, she held a number of senior management role at European biotech firms including CFO at Movetis, non-executive board member at
More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.
Featured jobs
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Healthcare Communications
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
Subscribe to our email news alerts
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
- The evolution of real-world studies
- How industry and regulators are using real-world data...
Quick links
Infographics
